Glenmark Pharma share price has plunged 3% and is presently trading at Rs 1,448.0.
Meanwhile, the BSE HEALTHCARE index is at 40,955.5 (up 0.4%).
Among the top losers in the BSE HEALTHCARE index today are IPCA Labs (down 1.0%) and ALKEM LABORATORIES (down 0.6%).
GSK Pharma (up 2.5%) and J.B.Chemicals (up 2.4%) are among the top gainers today.
Over the last one year, Glenmark Pharma has moved up from Rs 797.6 to Rs 1,448.0, registering a gain of Rs 650.5 (up 81.6%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 40,955.5, registering a gain of 47.2% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 130.4%), Jubilant Pharmova (up 104.3%) and GSK Pharma (up 104.1%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,740.3 (up 0.8%).
The top gainers among the BSE Sensex today are M&M (up 2.6%) and Tata Motors (up 2.2%). The most traded stocks in the BSE Sensex are Tata Steel and Nestle.
In the meantime, NSE Nifty is at 24,393.4 (up 1.0%). M&M and Tata Motors are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 79,740.3, registering a gain of 14,338.4 points (up 21.9%).
Glenmark Pharma net profit grew 803.0% YoY to Rs 3,402 million for the quarter ended June 2024, compared to a profit of Rs 377 million a year ago. Net sales rose 6.9% to Rs 32,442 million during the period as against Rs 30,361 million in April-June 2023.
For the year ended March 2023, Glenmark Pharma reported 62.0% decrease in net profit to Rs 3,774 million compared to net profit of Rs 9,936 million during FY22. Revenue of the company grew 5.6% to Rs 129,901 million during FY23.
The current Price to earnings ratio of Glenmark Pharma, based on rolling 12 month earnings, stands at -26.7.
Equitymaster requests your view! Post a comment on "Glenmark Pharma Plunges 3%; BSE HEALTHCARE Index Up 0.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!